Ben Sutton

Ben Sutton is an experienced Analyst at Dimensional Fund Advisors since May 2023, previously serving as a Senior Account Associate at Real Chemistry from January 2022 to May 2023. Prior experience includes a role as a Product Scientist at Attomarker Ltd, where responsibilities involved the development and deployment of antibody profiling equipment for COVID-19. Ben also worked as an Innovation Scientist at GSK, leading the development of a semisolid formulation and a bespoke chewing stimulator. Early career experience includes being a Support Worker at Achieving for Children, supporting children with complex needs. Ben holds a Bachelor of Science in Biological Sciences with Professional Placement from the University of Exeter, graduated in 2021.